Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 19 NOK -4.52%
Market Cap: 970.3m NOK

Arcticzymes Technologies ASA
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Arcticzymes Technologies ASA
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Arcticzymes Technologies ASA
OSE:AZT
Stock-Based Compensation
kr4.2m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Circio Holding ASA
OSE:CRNA
Stock-Based Compensation
kr618k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Stock-Based Compensation
kr4m
CAGR 3-Years
1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zelluna ASA
OSE:ZLNA
Stock-Based Compensation
kr3.3m
CAGR 3-Years
-43%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Arcticzymes Technologies ASA
Glance View

Market Cap
970.4m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
HIDDEN
Show

See Also

What is Arcticzymes Technologies ASA's Stock-Based Compensation?
Stock-Based Compensation
4.2m NOK

Based on the financial report for Jun 30, 2025, Arcticzymes Technologies ASA's Stock-Based Compensation amounts to 4.2m NOK.

What is Arcticzymes Technologies ASA's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 3Y
34%

Over the last year, the Stock-Based Compensation growth was 9%. The average annual Stock-Based Compensation growth rates for Arcticzymes Technologies ASA have been 34% over the past three years .

Back to Top